Work productivity in rhinitis using cell phones: The MASK pilot study

• DOI: 10.1111/all.13177
• Publication Date: 2017-04-07T15:37:52Z
• Authors: J. Bousquet; M. Bewick; S. Arnavielhe; E. Mathieu‐Dupas; R. Murray; A. Bedbrook; D. P. Caimmi; O. Vandenplas; P. W. Hellings; C. Bachert; J. M. Anto; K. C. Bergmann; C. Bindslev‐Jensen; S. Bosnic‐Anticevich; J. Bouchard; G. W. Canonica; N. H. Chavannes; A. A. Cruz; R. Dahl; P. Demoly; G. De Vries; P. Devillier; A. Fink‐Wagner; W. J. Fokkens; J. Fonseca; N. A. Guldemond; T. Haahtela; B. Hellqvist‐Dahl; J. Just; T. Keil; L. Klimek; M. L. Kowalski; P. Kuna; V. Kvedariene; D. Laune; D. Larenas‐Linnemann; J. Mullol; A. M. Pereira; P. Carreiro‐Martins; E. Melén; M. Morais‐Almeida; L. Nogueira‐Silva; R. E. O'Hehir; N. G. Papadopoulos; G. Passalacqua; F. Portejoie; D. Price; D. Ryan; B. Samolinski; A. Sheikh; F. E. R. Simons; O. Spranger; A. Todo Bom; P. V. Tomazic; M. Triggiani; A. Valero; E. Valovirta; A. Valiulis; M. van Eerd; M. Wickman; I. Young; T. Zuberbier
• Keywords: Work productivity

Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data assess the impact on work productivity uncontrolled assessed by visual analogue scale (VAS). A mobile app (Allergy Diary, Google Play Store Apple App Store) collects from daily scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) asthma (VAS-asthma) as well (VAS-work). combined nasal-ocular score is calculated. Allergy Diary available in 21 countries. includes Work Productivity Activity Impairment Specific Questionnaire (WPAI:AS) six EU All consecutive users who completed VAS-work 1 June 31 October 2016 were included study. total 1136 filled 5818 days VAS-work. Symptoms controlled <20) approximately 60% days. In with rhinitis, 90% had some impairment over 50% severe (VAS-work >50). There a significant correlation between VAS-global calculated (Rho=0.83, P<0.00001, Spearman's rank test). 144 users, there WPAI:AS (Rho=0.53, P<0.0001). This pilot provides not only proof-of-concept collected but also itself, especially distribution responses VAS. supports interpretation that persons report both presence absence symptoms.